Angiotech Pharmaceuticals Inc. plans to sell its interventional products unit to Argon Medical Devices Inc. for $362.5 million in cash, the firms announced March 25.
For Angiotech, the deal, expected to close in April, provides a means to pay down its debts. The acquisition, meanwhile,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?